Categories: CancerNews

RaySearch’s CEO sells shares – remains a long-term shareholder

STOCKHOLM, Sept. 27, 2024 /PRNewswire/ — RaySearch’s founder and CEO, Johan Löf, has sold 150,000 Class B shares in RaySearch Laboratories AB (publ) on September 24, 2024. Johan Löf remains a long-term shareholder and after the transaction owns 5,443,084 Class A shares and 68,393 Class B shares, corresponding to 16.1 percent of the total number of shares and 52.8 percent of the total number of votes in the company.

Johan Löf, founder and CEO, RaySearch: “The sale is due to private financial reasons. I remain committed to the company with continued strong confidence in RaySearch’s future. We are well positioned for continued growth, and I look forward to continuing to lead and develop RaySearch towards our strategic goals.”

The transaction has been reported to the Swedish Financial Supervisory Authority (Finansinspektionen) according to current regulations.

ABOUT RAYSEARCH

RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation®* treatment planning system (TPS) and the oncology information system (OIS) RayCare®*. The most recent additions to the RaySearch product line are RayIntelligence® and RayCommand®*. RayIntelligence is an oncology analytics system (OAS) which enables cancer clinics to collect, structure and analyze data. RayCommand, a treatment control system (TCS), is designed to link the treatment machine and the treatment planning and oncology information systems. 

RaySearch’s software has been sold to over 1,000 clinics in 43 countries. The company was founded in 2000 as a spin-off from the Karolinska Institute in Stockholm and the share has been listed on Nasdaq Stockholm since 2003. More information is available at raysearchlabs.com.

* Subject to regulatory clearance in some markets. 

FOR MORE INFORMATION, PLEASE CONTACT:
Johan Löf, founder and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0) 8 510 530 00 
johan.lof@raysearchlabs.com

Learn more about us on:
LinkedIn
YouTube
X

This information was brought to you by Cision http://news.cision.com.

https://news.cision.com/raysearch-laboratories/r/raysearch-s-ceo-sells-shares—remains-a-long-term-shareholder,c4044028

The following files are available for download:

https://mb.cision.com/Main/1102/4044028/3027561.pdf

RaySearch Press Release, September 27, 2024_

 

View original content:https://www.prnewswire.com/news-releases/raysearchs-ceo-sells-shares–remains-a-long-term-shareholder-302261179.html

SOURCE RaySearch Laboratories

Staff

Recent Posts

InventHelp Inventor Develops Assistive Device to Support Head (SCO-259)

PITTSBURGH, Sept. 27, 2024 /PRNewswire/ -- "I'm a certified nursing assistant, and I thought there…

31 mins ago

Eschenbach Introduces Optaro® – the Video Magnifier Made for Your Smartphone

DANBURY, Conn., Sept. 26, 2024 /PRNewswire/ -- Eschenbach Optik of America, Inc., a leading manufacturer…

31 mins ago

InventHelp Inventor Develops New Fire Detection and Suppressant Tower (SBT-1869)

PITTSBURGH, Sept. 27, 2024 /PRNewswire/ -- "I invented a device in the hopes it would…

31 mins ago

TraceLink Propels Organizations Toward DSCSA Compliance Ahead of the November 2024 Deadline

BOSTON, Sept. 27, 2024 /PRNewswire/ -- With the Drug Supply Chain Security Act (DSCSA) stabilization period…

32 mins ago

Ping An Healthcare and Technology Stock Soared 10% – Managed Care Takes Center Stage in Corporate Health Management

SHANGHAI, Sept. 27, 2024 /PRNewswire/ -- On September 26, 2024, Ping An Healthcare and Technology…

32 mins ago

CluePoints Launches Medical & Safety Review (MSR) Software to Revolutionize Clinical Data Review

CluePoints furthers its commitment to delivering innovative solutions that enhance clinical trial efficiency with this…

32 mins ago